Denizot Y et al. |
PAF and hematopoiesis. VIII. Biosynthesis and metabolism of PAF by human bone marrow stromal cells. |
1996 |
Exp. Hematol. |
pmid:8862444
|
Wang X et al. |
Potentiation of acetylcholine-induced responses in freshly isolated rabbit aortic endothelial cells. |
1996 Sep-Oct |
J. Vasc. Res. |
pmid:8862147
|
Saito H et al. |
Histamine augments VCAM-1 expression on IL-4- and TNF-alpha-stimulated human umbilical vein endothelial cells. |
1996 |
Int. Arch. Allergy Immunol. |
pmid:8859220
|
Jouët P and Sarna SK |
Platelet-activating factor (PAF) stimulates giant migrating contractions during ileal inflammation. |
1996 |
J. Pharmacol. Exp. Ther. |
pmid:8858995
|
Shi LC et al. |
Guanine nucleotide regulatory proteins, Gq and Gi1/2, mediate platelet-activating factor-stimulated phosphoinositide metabolism in immortalized hippocampal cells. |
1996 |
J. Neurochem. |
pmid:8858930
|
Lopes-Martins R et al. |
Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure. |
1996 |
Eur. J. Pharmacol. |
pmid:8858301
|
Abu-Zidan FM et al. |
Role of platelet-activating factor antagonism in posthemorrhage septic shock in pigs. |
1996 |
J Trauma |
pmid:8858021
|
Mastroroberto P et al. |
Elevated circulating levels of von Willebrand factor and D-dimer in patients with heart failure and mechanical prosthesis. |
1996 |
Scand J Thorac Cardiovasc Surg |
pmid:8857679
|
Albert DH et al. |
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats. |
1996 |
Shock |
pmid:8856845
|
Chen CC et al. |
Tumor necrosis factor-alpha, platelet-activating factor, and hydrogen peroxide activate protein kinase C subtypes alpha and epsilon in human saphenous vein endothelial cells. |
1996 |
J. Cardiovasc. Pharmacol. |
pmid:8856479
|
Ebara T et al. |
Role of platelet-activating factor and prostanoids in hemodynamic changes in rat experimental endotoxic shock. |
1996 |
Jpn. J. Pharmacol. |
pmid:8854207
|
Gaylord MS et al. |
Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia. |
1996 |
Am. J. Med. Sci. |
pmid:8853062
|
Hoffman BF et al. |
Arrhythmias caused by platelet activating factor. |
1996 |
J. Cardiovasc. Electrophysiol. |
pmid:8853022
|
Renesto P et al. |
Protective effect of platelet activating factor antagonists on cultured endothelial cell lysis induced by elastase or activated neutrophils. |
1996 |
Br. J. Pharmacol. |
pmid:8851508
|
Hahn M et al. |
Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): effects on intracellular calcium and platelet aggregation. |
1995 |
Cardiovasc Drugs Ther |
pmid:8850387
|
Yokota K et al. |
Inhibitory effects of the new anti-platelet agent KBT-3022 and its metabolite on rabbit neutrophil function in vitro. |
1996 |
Jpn. J. Pharmacol. |
pmid:8847836
|
Libert C et al. |
Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality. |
1995-1996 |
J. Inflamm. |
pmid:8844494
|
Kemény L et al. |
Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice. |
1996 |
Arch. Dermatol. Res. |
pmid:8844132
|
Paulino N et al. |
Mechanisms involved in the contractile responses induced by the hydroalcoholic extract of Phyllanthus urinaria on the guinea pig isolated trachea: evidence for participation of tachykinins and influx of extracellular Ca2+ sensitive to ruthenium red. |
1996 |
Gen. Pharmacol. |
pmid:8842681
|
Tenor H et al. |
Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. |
1996 |
Br. J. Pharmacol. |
pmid:8842438
|
Isogai E et al. |
[Platelet activating factor (PAF) and Lyme disease]. |
1996 |
Nippon Saikingaku Zasshi |
pmid:8840817
|
Imagawa M et al. |
Modulation of platelet-activating factor synthesis by recombinant interferon-alpha in human renal cell carcinoma. |
1996 |
Urol. Int. |
pmid:8840484
|
Kurata M et al. |
A comparative study of whole-blood platelet aggregation in laboratory animals: its species differences and comparison with turbidimetric method. |
1995 |
Comp. Biochem. Physiol. C, Pharmacol. Toxicol. Endocrinol. |
pmid:8838690
|
Louis RE and Radermecker MF |
Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine. |
1996 |
Eur. Respir. J. |
pmid:8836652
|
Barkai U and Kraicer PF |
Intrauterine signaling and embryonic implantation. |
1996 Mar-Apr |
Biol. Signals |
pmid:8836494
|
Taylor ML et al. |
Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects. |
1996 |
Clin. Exp. Allergy |
pmid:8835129
|
Gabryelewicz A |
Etiology and pathogenesis of acute pancreatitis--current view. |
1995 |
Rocz. Akad. Med. Bialymst. |
pmid:8834603
|
Matsuo Y et al. |
Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain. |
1996 |
Brain Res. |
pmid:8833766
|
Tsukioka K et al. |
Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. |
1996 Jan-Feb |
J Investig Allergol Clin Immunol |
pmid:8833165
|
Savu SR et al. |
Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry. |
1996 |
J. Chromatogr. B, Biomed. Appl. |
pmid:8832423
|
Ribaldi E et al. |
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation. |
1996 |
Br. J. Pharmacol. |
pmid:8832056
|
Sandoval D et al. |
The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. |
1996 |
Gastroenterology |
pmid:8831604
|
Galloway SW and Kingsnorth AN |
Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist. |
1996 |
Pancreas |
pmid:8829181
|
Spangelo BL and Jarvis WD |
Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro. |
1996 |
Endocrinology |
pmid:8828503
|
López-Novoa JM et al. |
The role of platelet-activating factor and the effect of PAF blocking receptors on the outcome of ARF. |
1996 |
Ren Fail |
pmid:8827995
|
Grinyó JM et al. |
The role of platelet-activating factor antagonists in the prophylaxis of posttransplant acute tubular necrosis. |
1996 |
Ren Fail |
pmid:8827990
|
Burt RP et al. |
The role of diacylglycerol and activation of protein kinase C in alpha 1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens. |
1996 |
Br. J. Pharmacol. |
pmid:8825367
|
Predescu D et al. |
The vascular distribution of the platelet-activating factor receptor. |
1996 |
Eur. J. Cell Biol. |
pmid:8825027
|
Yang HO et al. |
Biological and pharmacological effects of pinusolide, a novel platelet activating factor antagonist. |
1995 |
Planta Med. |
pmid:8824945
|
Murakami K et al. |
A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats. |
1996 |
Thromb. Haemost. |
pmid:8822594
|
Miguélez R et al. |
Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. |
1996 |
J Lipid Mediat Cell Signal |
pmid:8821809
|
Kuitert L and Barnes NC |
PAF and asthma--time for an appraisal? |
1995 |
Clin. Exp. Allergy |
pmid:8821294
|
Lin J et al. |
Effects of platelet-activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. |
1996 |
Acta Otolaryngol. |
pmid:8820353
|
Abu-Zidan FM and Walther S |
Platelet activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs. |
1996 |
Eur J Surg |
pmid:8817228
|
Le Solleu H et al. |
A pharmacophore for high affinity PAF antagonists. I. Electronic model using molecular electrostatic potential. |
1996 |
J Lipid Mediat Cell Signal |
pmid:8816988
|
Le Texier L et al. |
Structure-activity relationships in platelet-activating factor (PAF). 8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: anti-acetylcholinesterase activity and comparative SAR. |
1996 |
J Lipid Mediat Cell Signal |
pmid:8816985
|
Le Texier L et al. |
Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity. |
1996 |
J Lipid Mediat Cell Signal |
pmid:8816984
|
Bauldry SA and Wooten RE |
Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation. |
1996 |
Biochim. Biophys. Acta |
pmid:8816854
|
Sato E et al. |
Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity. |
1996 |
J. Immunol. |
pmid:8816423
|
Erger RA and Casale TB |
Eosinophil migration in response to three molecular species of platelet activating factor. |
1996 |
Inflamm. Res. |
pmid:8814455
|